Big pharma companies hit with FDA warning letters in drug ad clampdown
The US Food and Drug Administration (FDA) has followed up on its promise to clampdown on misleading and deceptive drug…
News
Eli Lilly picks Virginia for $5bn drug manufacturing plant
VarmX and CSL form alliance for blood coagulation treatment development
GSK plans $30bn investment for R&D in US
Reunion Neuroscience expands Series A to $133m after positive trial milestones
Novo Nordisk secures EMA approval for Rybelsus label update
aTyr Pharma stock crashes on Phase III pulmonary sarcoidosis fail
Cadrenal Therapeutics acquires eXIthera’s Factor XIa inhibitors
